Thanks Shane re: info about the webinar.
The entity's performance. imo, was poor whether based on creating SH wealth, imo the prime reason anyone would invest or based on company finances (sales/profitability).
Further, PO's original shorter and longer term incentives, Performance Shares A and B, expired due to the company, under his leadership, being unable to hit the targets aka poor performance.
PO's only incentive should be to ensure the value of his holdings increase; the same as every other investor in NOR.
New question for PO:
Based on SH's delivering a first strike to the BoD, rejecting the Remuneration Report, do you want to consider new consultants or using the less expensive option, common sense?
- Forums
- ASX - By Stock
- NOR
- Ann: Norwood Investor Webinair Q&A - Tuesday 11 December 2018
Ann: Norwood Investor Webinair Q&A - Tuesday 11 December 2018, page-10
Featured News
Add NOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.24M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 26342 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 64999 | 0.032 |
1 | 100000 | 0.031 |
1 | 13400 | 0.030 |
1 | 96000 | 0.028 |
1 | 180000 | 0.027 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 26342 | 1 |
0.039 | 126001 | 1 |
0.040 | 123849 | 1 |
0.042 | 23833 | 1 |
0.044 | 44101 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
NOR (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online